Allmed Solutions (XTAE:ALMD) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Allmed Solutions FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Allmed Solutions's Free Cash Flow for the six months ended in Dec. 2023 was ₪-3.67 Mil. Allmed Solutions's Revenue for the six months ended in Dec. 2023 was ₪0.00 Mil. Therefore, Allmed Solutions's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Allmed Solutions's current FCF Yield % is 20.86%.

The historical rank and industry rank for Allmed Solutions's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Allmed Solutions was -92.06%. The lowest was -394.91%. And the median was -206.40%.

XTAE:ALMD's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -7.07
* Ranked among companies with meaningful FCF Margin % only.

Allmed Solutions FCF Margin % Historical Data

The historical data trend for Allmed Solutions's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allmed Solutions FCF Margin % Chart

Allmed Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-111.32

-92.06

-99.57

Allmed Solutions Semi-Annual Data
	Dec12	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-1,825.97	-	-	-	-

Competitive Comparison of Allmed Solutions's FCF Margin %

For the Medical Devices subindustry, Allmed Solutions's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allmed Solutions's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allmed Solutions's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Allmed Solutions's FCF Margin % falls into.

Allmed Solutions FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Allmed Solutions's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	7.017	/	0
	=	%

Allmed Solutions's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.669	/	0
	=	%

Allmed Solutions FCF Margin % Related Terms

Thank you for viewing the detailed overview of Allmed Solutions's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Allmed Solutions (XTAE:ALMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allmed Solutions Ltd (XTAE:ALMD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ha-Eshel Street, P.O.BOX 3081, Caesarea Industrial Park, Caesarea, ISR, 3079501

Website

https://www.almd-solutions.com

Allmed Solutions Ltd is a medical device company. It researches, develops, manufactures and markets peripheral stents and medical devices. It has developed a proprietary stent technology platform to expedite the development of site-specific stents. It also develops medical devices focused on minimal invasive therapy for the treatment of type 2 diabetes.

Allmed Solutions (XTAE:ALMD) Headlines

No Headlines